ARTICLE | Clinical News
InnaVirVax preclinical data
July 18, 2011 7:00 AM UTC
In rats, repeated intramuscular injections with VAC-3S did not result in toxicity or lesion formation. VAC-3S is a gp41 peptide that inhibits decreases in CD4+ T cell count. ...